weight loss drug news today glp-1 october 2025 Alarming rise in overdoses obesity drug news today glp-1

Licensed providers evaluate and prescribe when appropriate

Call our clinic at (954) 551-3508 between 9:00 AM 10:00 PM , and our patient coordinator will assist you and send your intake form

All office visits, consultations, and follow-ups are completely free

Daz-Trastoy O, Villar-Taibo R, Sifontes-Dubn M, et al

PLoS ONE 10 , e0130894 (2015)

Centers for Disease Control and Prevention (CDC) data show that more than 100 million US adults are obese, PwC noted, while an analysis published in JAMA Cardiology in November determined that 137 million Americans may be eligible for the GLP-1 drug semaglutide (prescribed as Wegovy for weight loss and Ozempic for type 2 diabetes)